Spiro-indolines as Y5 receptor antagonists
US6191160A · kind A · utility
9Cited by
6References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 8, 1999 |
| Grant date | Feb 20, 2001 |
| Priority date | — |
| Expiry date | Nov 8, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the general structural formula I ##STR1## are selective NPY Y5 receptor antagonists. The compounds and compositions of the present invention are useful in the treatment of obesity and complications associated therewith.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.